Sirolimus
Definition
Sirolimus is indicated by the Food and Drug Administration (FDA) to be used after a kidney transplant to prevent the body from rejecting the new kidney. Sirolimus may also have a role in prevention of organ rejection in heart or lung transplantation, and prevention of graft-versus-host disease in patients undergoing bone marrow transplantation. Sirolimus (formerly known as rapamycin) became available at the end of 1999 and is marketed under the brand name Rapamune by Wyeth-Ayerst Laboratories.
Description
Sirolimus belongs to a class of macrolide antibiotics and is isolated from an organism named streptomyces...
[The entire page is 1327 words long]
Join eNotes
Over 3,500 study guides, question and answer forums, literature criticism, reference content, and much more!
